Future horizons in the treatment of enteric neuropathies

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue SUPPL. 2, 2007, Pages

  Thapar, Nikhil ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Enteric nervous system; Neuropathies; Stem cells; Therapies

Indexed keywords

SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

CENTRAL VENOUS CATHETERIZATION; CONFERENCE PAPER; ENTERIC FEEDING; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT FUNCTION; HEREDITY; HIRSCHSPRUNG DISEASE; HUMAN; IMMUNOTHERAPY; INTESTINE INNERVATION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MORBIDITY; MORTALITY; MOTOR PERFORMANCE; NERVE CELL; NEUROPATHY; NEUROSECRETORY CELL; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; CHILD; ENTERIC NERVOUS SYSTEM; HUMANS; INTESTINES; NERVOUS SYSTEM DISEASES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 38149140855     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31812e667c     Document Type: Conference Paper

References (58)

1. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil 2004;16:515-31.
2. De Giorgio R, Guerrini S, Barbara G, et al. New insights into human enteric neuropathies. Neurogastroenterol Motil 2004;16 (Suppl 1):143-7.
3. Milla PJ. Acquired motility disorders in childhood. Can J Gastroenterol 1999;13:76A-84A.
4. Milla PJ. Motility disorders in childhood. Baillieres Clin Gastroenterol 1998;12:775-97.
5. Milla PJ. Gastrointestinal motility disorders in children. Pediatr Clin North Am 1988;35:311-30.
6. Milla P, Cucchiara S, DiLorenzo C, et al. Motility disorders in childhood: working group report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2002;35 (Suppl 2):S187-95.
7. Grundy D, Schemann M. Enteric nervous system. Curr Opin Gastroenterol 2006;22:102-10.
8. Bassotti G, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol 2006;12:4609-13.
9. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Minneap) 1999;34:31-2, 35-8, 41-2.
10. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 2000;81:87-96.
11. Furness JB. The Enteric Nervous System. Oxford, UK: Blackwell; 2005.
12. Heneyke S, Smith VV, Spitz L, et al. Chronic intestinal pseudoobstruction: treatment and long term follow-up of 44 patients. Arch Dis Child 1999;81:21-7.
13. Duran B. The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review. BMC Nurs 2005;4:2.
14. Guglielmi FW, Boggio-Bertinet D, Federico A, et al. Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 2006;38:623-42.
15. Mousa H, Hyman PE, Cocjin J, et al. Long-term outcome of congenital intestinal pseudo-obstruction. Dig Dis Sci 2002;47:2298-305.
16. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006;130:S70-7.
17. Revel-Vilk S. Central venous line-related thrombosis in children. Acta Haematol 2006;115:201-6.
18. Tsuji H, Spitz L, Kiely EM, et al. Management and long-term follow-up of infants with total colonic aganglionosis. J Pediatr Surg 1999;34:158-62.
19. Ludman L, Spitz L, Tsuji H, et al. Hirschsprung's disease: functional and psychological follow-up comparing total colonic and rectosigmoid aganglionosis. Arch Dis Child 2002;86:348-51.
20. Burns AJ, Pasricha PJ, Young HM. Enteric neural crest-derived cells and neural stem cells: biology and therapeutic potential. Neurogastroenterol Motil 2004;16 (Suppl 1):3-7.
21. Hansen MB. The enteric nervous system III: a target for pharmacological treatment. Pharmacol Toxicol 2003;93:1-13.
22. Meyer T, Brinck U. Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract. Digestion 1999;60:63-8.
23. Glatzle J, Sternini C, Robin C, et al. Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology 2002;123:217-26.
24. Smith VV, Gregson N, Foggensteiner L, et al. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997;112:1366-71.
25. Schappi MG, Smith VV, Milla PJ, et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003;52:752-5.
26. De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002;97:2454-9.
27. De Giorgio R, Guerrini S, Barbara G, et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 2004;126:1872-83.
28. Ruuska TH, Karikoski R, Smith VV, et al. Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 2002;122:1133-9.
29. Zhang J, Chen JD. Pacing the gut in motility disorders. Curr Treat Options Gastroenterol 2006;9:351-60.
30. Shafik A, Shafik AA, El-Sibai O, et al. Colonic pacing: a therapeutic option for the treatment of constipation due to total colonic inertia. Arch Surg 2004;139:775-9.
31. Shafik A, El-Sibai O, Shafik AA. Rectal pacing in patients with constipation due to rectal inertia: technique and results. Int J Colorectal Dis 2000;15:100-4.
32. Goulet O, Sauvat F. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care 2006;9:304-13.
33. Goulet O, Sauvat F, Ruemmele F, et al. Results of the Paris program: ten years of pediatric intestinal transplantation. Transplant Proc 2005;37:1667-70.
34. Longworth L, Young T, Beath SV, et al. An economic evaluation of pediatric small bowel transplantation in the United Kingdom. Transplantation 2006;82:508-15.
35. Castillo RO, Zarge R, Cox K, et al. Pediatric intestinal transplantation at Packard Children's Hospital/Stanford University Medical Center: report of a four-year experience. Transplant Proc 2006;38:1716-7.
36. Sauvat F, Dupic L, Caldari D, et al. Factors influencing outcome after intestinal transplantation in children. Transplant Proc 2006;38:1689-91.
37. Beath SV. Closure and summary of Ninth International Small Bowel Transplantation Symposium. Transplant Proc 2006;38:1657-8.
38. Beath SV, Protheroe SP, Brook GA, et al. Early experience of paediatric intestinal transplantation in the United Kingdom, 1993 to 1999. Transplant Proc 2000;32:1225.
39. Gupte GL, Beath SV, Protheroe S, et al. Improved outcome of referrals for intestinal transplantation in the UK. Arch Dis Child 2007;92:147-52.
40. Gupte GL, Beath SV, Millar AJ, et al. Is this really the current status of small bowel transplantation in the UK? Gut 2006;55:903.
41. Burns AJ, Thapar N. Advances in ontogeny of the enteric nervous system. Neurogastroenterol Motil 2006;18:876-87.
42. Wallace AS, Burns AJ. Spatiotemporal migration of neural crest cells within the human gastrointestinal tract. Neurogastroenterol Motil 2003;15:201.
43. Wallace AS, Burns AJ. Development of the enteric nervous system, smooth muscle, and interstitial cells of Cajal in the human gastrointestinal tract. Cell Tissue Res 2005;319:367-82.
44. Bixby S, Kruger GM, Mosher JT, et al. Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 2002;35:643-56.
45. Lo L, Anderson DJ. Postmigratory neural crest cells expressing c-RET display restricted developmental and proliferative capacities. Neuron 1995;15:527-39.
46. Morrison SJ, White PM, Zock C, et al. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999;96:737-49.
47. Natarajan D, Grigoriou M, Marcos-Gutierrez CV, et al. Multipotential progenitors of the mammalian enteric nervous system capable of colonising aganglionic bowel in organ culture. Development 1999;126:157-68.
48. Sidebotham EL, Kenny SE, Lloyd DA, et al. Location of stem cells for the enteric nervous system. Pediatr Surg Int 2002;18:581-5.
49. Kruger GM, Mosher JT, Bixby S, et al. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002;35:657-69.
50. Bondurand N, Natarajan D, Thapar N, et al. Neuron and glia generating progenitors of the mammalian enteric nervous system isolated from foetal and postnatal gut cultures. Development 2003;130:6387-400.
51. Thapar N, Natarajan D, Caldwell C, et al. Enteric system progenitors from Hirschsprung's-like gut. Neurogastroenterol Motil 2006;18:763.
52. de Graaff E, Srinivas S, Kilkenny C, et al. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev 2001;15:2433-44.
53. Bondurand N, Natarajan D, Barlow A, et al. Maintenance of mammalian enteric nervous system progenitors by SOX10 and endothelin 3 signalling. Development 2006;133:2075-86.
54. Barlow A, de Graaff E, Pachnis V. Enteric nervous system progenitors are coordinately controlled by the G protein-coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 2003;40:905-16.
55. Young HM, Hearn CJ, Farlie PG, et al. GDNF is a chemoattractant for enteric neural cells. Dev Biol 2001;229:503-16.
56. Natarajan D, Marcos-Gutierrez C, Pachnis V, et al. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 2002;129:5151-60.
57. Thrasivoulou C, Soubeyre V, Ridha H, et al. Reactive oxygen species, dietary restriction, and neurotrophic factors in age-related loss of myenteric neurons. Aging Cell 2006;5:247-57.
58. Wade PR, Hornby PJ. Age-related neurodegenerative changes and how they affect the gut. Sci Aging Knowledge Environ 2005;23:pe8.